Current Neuropharmacology
Title:Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times
Volume: 19 Issue: 2
Author(s): Seyed Mohammad Nabavi*Eduardo Sobarzo-Sánchez*
Affiliation:
- Applied Biotechnology Research Center Baqiyatallah University of Medical Sciences Tehran, Sheikh Bahaei St., 19945-546,Iran
- Grupo de Investigación en Química Médica y Bio-inorgánica (QMEDBIN) Facultad de Ciencias de la Salud Universidad Central de Chile Lord Cochrane 417, Santiago,Spain
Export Options
About this article
Cite this article as:
Nabavi Mohammad Seyed *, Sobarzo-Sánchez Eduardo *, Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times, Current Neuropharmacology 2021; 19 (2) . https://dx.doi.org/10.2174/1570159X1902201231153120
DOI https://dx.doi.org/10.2174/1570159X1902201231153120 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Role of Blood-Brain Barrier Transporters in Pathophysiology and Pharmacotherapy of Stroke
Current Pharmaceutical Design Pharmaceutical and Biomedical Analysis of Terpene Constituents in Salvia miltiorrhiza
Current Pharmaceutical Analysis Ceramide Involvement in Apoptosis and Apoptotic Diseases
Mini-Reviews in Medicinal Chemistry Rivastigmine Transdermal Patch and Physical Exercises for Alzheimer's Disease: A Randomized Clinical Trial
Current Alzheimer Research GABAergic Modulation in Diabetic Encephalopathy-Related Depression
Current Pharmaceutical Design Mood Disorders in Elderly Population: Neurostimulative Treatment Possibilities
Recent Patents on CNS Drug Discovery (Discontinued) The Dopaminergic System in Peripheral Blood Lymphocytes: From Physiology to Pharmacology and Potential Applications to Neuropsychiatric Disorders
Current Neuropharmacology Origins, Controversies and Recent Developments of the MCI Construct
Current Alzheimer Research TREM2 and the Progression of Alzheimer’s Disease
Current Neurovascular Research O-GlcNAc Modification and the Tauopathies: Insights from Chemical Biology
Current Alzheimer Research Aporphines and Parkinson’s Disease: Medical Tools for the Future
Current Topics in Medicinal Chemistry The Possible Involvement of HLA Class III Haplotype (RAGE, HSP70 and TNF Genes) in Alzheimer's Disease
Current Alzheimer Research Geriatric Depression - Review for Primary Care
Current Psychiatry Reviews Diuretic-Associated Electrolyte Disorders in the Elderly: Risk Factors, Impact, Management and Prevention
Current Drug Safety Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia
Central Nervous System Agents in Medicinal Chemistry Vascular Effects of Ambient Pollutant Particles and Metals
Current Vascular Pharmacology Immunopharmacology of the Main Herbal Supplements: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina
Current Alzheimer Research Parkinson's Disease: A Role for the Immune System
Current Molecular Pharmacology Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Current Medicinal Chemistry